{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:02Z","timestamp":1792783022995,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Youth S&T Talent Support Programme of Guangdong Provincial Association for Science and Technology","award":["SKXRC2025347"],"award-info":[{"award-number":["SKXRC2025347"]}],"id":[{"id":"https:\/\/ror.org\/035vmht26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072993"],"award-info":[{"award-number":["82072993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province","award":["2021A1515011139"],"award-info":[{"award-number":["2021A1515011139"]}]},{"name":"the Science and Technology Projects in Guangzhou","award":["2025A03J4331"],"award-info":[{"award-number":["2025A03J4331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10055-z","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:21:22Z","timestamp":1783156882000},"page":"5363-5377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of a Crotonylation-Related Prognostic Risk Model for Cholangiocarcinoma Based on Integrative Transcriptome Analysis"],"prefix":"10.1007","volume":"71","author":[{"given":"Xinlei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"10055_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10055_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall T, Verheij J, Gaudio E et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39:7\u201318.","journal-title":"Liver Int."},{"key":"10055_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE et al. Cholangiocarcinoma. . Nat Rev Dis Primers. 2021;7:65.","journal-title":". Nat Rev Dis Primers."},{"key":"10055_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvis\u00e9 M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39:98\u2013107.","journal-title":"Liver Int."},{"key":"10055_CR5","doi-asserted-by":"publisher","first-page":"2310196","DOI":"10.1080\/07853890.2024.2310196","volume":"56","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S. Advances in targeted therapy of cholangiocarcinoma. Ann Med. 2024;56:2310196.","journal-title":"Ann Med."},{"key":"10055_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, Kelley RK, Kl\u00fcmpen HJ, Malka D et al. Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127\u2013140.","journal-title":"Ann Oncol."},{"key":"10055_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","volume":"20","author":"SI Ilyas","year":"2023","unstructured":"Ilyas SI, Affo S, Goyal L, Lamarca A, Sapisochin G, Yang JD et al. Cholangiocarcinoma - novel biological insights and therapeutic strategies. Nat Rev Clin Oncol. 2023;20:470\u2013486.","journal-title":"Nat Rev Clin Oncol."},{"key":"10055_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/0115665232323373240905104033","volume":"25","author":"J Lu","year":"2025","unstructured":"Lu J, Zhen S, Li X. Characteristics of oxidative phosphorylation-related subtypes and construction of a prognostic signature in ovarian cancer. Curr Gene Ther. 2025;25:327\u2013344.","journal-title":"Curr Gene Ther."},{"key":"10055_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/0113892029278082240118053857","volume":"25","author":"A Xing","year":"2024","unstructured":"Xing A, Lv D, Wu C, Zhou K, Zhao T, Zhao L et al. Tertiary lymphoid structures gene signature predicts prognosis and immune infiltration analysis in head and neck squamous cell carcinoma. Curr Genomics. 2024;25:88\u2013104.","journal-title":"Curr Genomics."},{"key":"10055_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye W, Wang J, Zheng J, Jiang M, Zhou Y, Wu Z. Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis. Protein Pept Lett. 2024;31:706\u2013713.","journal-title":"Protein Pept Lett."},{"key":"10055_CR11","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1007\/s12010-026-05655-4","volume":"198","author":"S Jiang","year":"2026","unstructured":"Jiang S, Leng P, Li Y, Song L, Xu X, Yang L. Comprehensive analysis of the roles of the CCDC protein family play in a range of 58 disease processes. Appl Biochem Biotechnol. 2026;198:3390.","journal-title":"Appl Biochem Biotechnol."},{"key":"10055_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nsmb.1842","volume":"17","author":"YL Deribe","year":"2010","unstructured":"Deribe YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol. 2010;17:666\u2013672.","journal-title":"Nat Struct Mol Biol."},{"key":"10055_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.biopha.2018.12.148","volume":"111","author":"J Wan","year":"2019","unstructured":"Wan J, Liu H, Ming L. Lysine crotonylation is involved in hepatocellular carcinoma progression. Biomed Pharmacother. 2019;111:976\u2013982.","journal-title":"Biomed Pharmacother."},{"key":"10055_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-025-07530-y","volume":"24","author":"L Song","year":"2025","unstructured":"Song L, Kong D, Yang L. Deciphering USP8\u2019s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas. J Transl Med. 2025;24:36.","journal-title":"J Transl Med."},{"key":"10055_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jhep.2024.05.034","volume":"81","author":"Y Lao","year":"2024","unstructured":"Lao Y, Cui X, Xu Z et al. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma. J Hepatol. 2024;81:847\u2013861.","journal-title":"J Hepatol."},{"key":"10055_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-2007-981195","volume":"132","author":"I Tischoff","year":"2007","unstructured":"Tischoff I, Tannapfel A. Hepatocellular carcinoma and cholangiocarcinoma\u2013different prognosis, pathogenesis and therapy. Zentralbl Chir. 2007;132:300\u2013305.","journal-title":"Zentralbl Chir."},{"key":"10055_CR17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/HEP.0000000000001259","volume":"82","author":"P Olaizola","year":"2025","unstructured":"Olaizola P, Olaizola I, Fernandez de Ara M et al. Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk. Hepatology. 2025;82:1461\u201379.","journal-title":"Hepatology."},{"key":"10055_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13062-024-00453-6","volume":"19","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang Y, Wu G, Sun N, Bai H, Li X et al. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination. Biol Direct. 2024;19:16.","journal-title":"Biol Direct."},{"key":"10055_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/cas.70061","volume":"116","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liu X, Liu Y, Zhu H, Zheng C, Ling Q et al. VCP Promotes cholangiocarcinoma development by mediating bap1 ubiquitination-dependent degradation. Cancer Sci. 2025;116:1579\u20131591.","journal-title":"Cancer Sci."},{"key":"10055_CR20","doi-asserted-by":"publisher","first-page":"4444869","DOI":"10.1155\/2023\/4444869","volume":"2023","author":"L Jiang","year":"2023","unstructured":"Jiang L, Yin X, Zhang H et al. Development and validation of a prognostic signature based on the lysine crotonylation regulators in head and neck squamous cell carcinoma. Biomed Res Int. 2023;2023:4444869.","journal-title":"Biomed Res Int."},{"key":"10055_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-021-03987-z","volume":"12","author":"G Jiang","year":"2021","unstructured":"Jiang G, Li C, Lu M, Lu K, Li H. Protein lysine crotonylation: past, present, perspective. Cell Death Dis. 2021;12:703.","journal-title":"Cell Death Dis."},{"key":"10055_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13072-021-00385-9","volume":"14","author":"K Li","year":"2021","unstructured":"Li K, Wang Z. Histone crotonylation-centric gene regulation. Epigenetics Chromatin. 2021;14:10.","journal-title":"Epigenetics Chromatin."},{"key":"10055_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.624914","volume":"9","author":"A Ntorla","year":"2021","unstructured":"Ntorla A, Burgoyne JR. The regulation and function of histone crotonylation. Front Cell Dev Biol. 2021;9:624914.","journal-title":"Front Cell Dev Biol."},{"key":"10055_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformat. 2008;9:559.","journal-title":"BMC Bioinformat."},{"key":"10055_CR25","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al. clusterprofiler 40 a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.","journal-title":"Innovation (Camb)."},{"key":"10055_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84\u201396.","journal-title":"Ann Surg."},{"key":"10055_CR27","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.7150\/thno.36276","volume":"9","author":"JC Lu","year":"2019","unstructured":"Lu JC, Zeng HY, Sun QM et al. Distinct PD-L1\/PD1 profiles and clinical implications in intrahepatic cholangiocarcinoma patients with different risk factors. Theranostics. 2019;9:4678\u20134687.","journal-title":"Theranostics."},{"key":"10055_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/apt.17623","volume":"58","author":"Z Lei","year":"2023","unstructured":"Lei Z, Ma W, Si A et al. Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma. Aliment Pharmacol Ther. 2023;58:611\u2013622.","journal-title":"Aliment Pharmacol Ther."},{"key":"10055_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41435-025-00362-2","volume":"26","author":"Y Li","year":"2025","unstructured":"Li Y, Bai S, Hu J, Li H, Hu C, Zhao J et al. Post-translational acylation modulates immunosuppression and immunotherapy efficacy in hepatocellular carcinoma. Genes Immun. 2025;26:599\u2013612.","journal-title":"Genes Immun."},{"key":"10055_CR30","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673381518250529110617","author":"W Su","year":"2025","unstructured":"Su W, Kang K, Li X, Huang H. A prognostic lysine crotonylation signature shapes the immune microenvironment in hepatocellular carcinoma. Curr Med Chem. 2025. https:\/\/doi.org\/10.2174\/0109298673381518250529110617.","journal-title":"Curr Med Chem"},{"key":"10055_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70083","volume":"28","author":"B Yang","year":"2024","unstructured":"Yang B, Wen F, Cui Y. Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. J Cell Mol Med. 2024;28:e70083.","journal-title":"J Cell Mol Med."},{"key":"10055_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ajpath.2024.08.014","volume":"195","author":"RV Guest","year":"2025","unstructured":"Guest RV, Goeppert B, Nault JC, Sia D. Morphomolecular pathology and genomic insights into the cells of origin of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Am J Pathol. 2025;195:345\u2013361.","journal-title":"Am J Pathol."},{"key":"10055_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216799","volume":"588","author":"S Jiang","year":"2024","unstructured":"Jiang S, Lu H, Pan Y, Yang A, Aikemu A, Li H et al. Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Lett. 2024;588:216799.","journal-title":"Cancer Lett."},{"key":"10055_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jhep.2022.11.030","volume":"78","author":"G Kendre","year":"2023","unstructured":"Kendre G, Murugesan K, Brummer T, Segatto O, Saborowski A, Vogel A. Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma. J Hepatol. 2023;78:614\u2013626.","journal-title":"J Hepatol."},{"key":"10055_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/ijms26072889","volume":"26","author":"ML Terra","year":"2025","unstructured":"Terra ML, Sant\u2019Anna TBF, de Barros JJF, de Araujo NM. Geographic and viral etiology patterns of TERT promoter and CTNNB1 exon 3 mutations in hepatocellular carcinoma: a comprehensive review. Int J Mol Sci. 2025;26:68.","journal-title":"Int J Mol Sci."},{"key":"10055_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.celrep.2016.04.038","volume":"15","author":"RT Bushey","year":"2016","unstructured":"Bushey RT, Moody MA, Nicely NL et al. A therapeutic antibody for cancer, derived from single human B cells. Cell Rep. 2016;15:1505\u20131513.","journal-title":"Cell Rep."},{"key":"10055_CR37","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1016\/j.vaccine.2008.11.021","volume":"26","author":"C Skerka","year":"2008","unstructured":"Skerka C, Zipfel PF. Complement factor H related proteins in immune diseases. Vaccine. 2008;26:I9-14.","journal-title":"Vaccine."},{"key":"10055_CR38","doi-asserted-by":"publisher","first-page":"1752827","DOI":"10.1155\/2022\/1752827","volume":"2022","author":"H Wang","year":"2022","unstructured":"Wang H, He M, Zhang Z, Yin W, Ren B, Lin Y. Low complement factor H-Related 3 (CFHR3) expression indicates poor prognosis and immune regulation in cholangiocarcinoma. J Oncol. 2022;2022:1752827.","journal-title":"J Oncol."},{"key":"10055_CR39","doi-asserted-by":"publisher","first-page":"1302490","DOI":"10.3389\/fcell.2024.1302490","volume":"12","author":"R Saxena","year":"2024","unstructured":"Saxena R, Gottlin EB, Campa MJ, Bushey RT, Guo J, Patz EF Jr et al. Complement factor H: a novel innate immune checkpoint in cancer immunotherapy. Front Cell Dev Biol. 2024;12:1302490.","journal-title":"Front Cell Dev Biol."},{"key":"10055_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0005-2760(97)00108-2","volume":"1348","author":"DE Vance","year":"1997","unstructured":"Vance DE, Walkey CJ, Cui Z. Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta. 1997;1348:142\u2013150.","journal-title":"Biochim Biophys Acta."},{"key":"10055_CR41","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1096\/fj.201900679R","volume":"33","author":"S Wan","year":"2019","unstructured":"Wan S, van der Veen JN, Bakala N\u2019Goma JC et al. Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance. Faseb j. 2019;33:10986\u201310995.","journal-title":"Faseb j."},{"key":"10055_CR42","doi-asserted-by":"publisher","first-page":"21721","DOI":"10.1038\/srep21721","volume":"6","author":"A Nakatsuka","year":"2016","unstructured":"Nakatsuka A, Matsuyama M, Yamaguchi S et al. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Sci Rep. 2016;6:21721.","journal-title":"Sci Rep."},{"key":"10055_CR43","doi-asserted-by":"publisher","first-page":"24531","DOI":"10.1016\/S0021-9258(17)31421-7","volume":"269","author":"Z Cui","year":"1994","unstructured":"Cui Z, Houweling M, Vance DE. Suppression of rat hepatoma cell growth by expression of phosphatidylethanolamine N-methyltransferase-2. J Biol Chem. 1994;269:24531\u201324533.","journal-title":"J Biol Chem."},{"key":"10055_CR44","first-page":"182","volume":"1","author":"DE Vance","year":"1996","unstructured":"Vance DE. Phosphatidylethanolamine N-methyltransferase: unexpected findings from curiosity-driven research. Eur J Med Res. 1996;1:182\u2013188.","journal-title":"Eur J Med Res."},{"key":"10055_CR45","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1080\/15548627.2023.2166276","volume":"19","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Zhong Q, Yan X. YWHAE\/14-3-3\u03b5 crotonylation regulates leucine deprivation-induced autophagy. Autophagy. 2023;19:2401\u20132402.","journal-title":"Autophagy."},{"key":"10055_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 2025;78:101170.","journal-title":"Drug Resist Updat."},{"key":"10055_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057968","volume":"8","author":"TA Liu","year":"2013","unstructured":"Liu TA, Jan YJ, Ko BS et al. 14-3-3\u03b5 overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS One. 2013;8:e57968.","journal-title":"PLoS One."},{"key":"10055_CR48","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/hmg\/ddz146","volume":"28","author":"H Bjeije","year":"2019","unstructured":"Bjeije H, Soltani BM, Behmanesh M, Zali MR. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras\/Erk1\/2 and PI3K\/Akt signaling pathways in HCT116 cells. Hum Mol Genet. 2019;28:3219\u20133231.","journal-title":"Hum Mol Genet."},{"key":"10055_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12935-021-01989-7","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Wang C, Wang S et al. YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K\/AKT and MAPK pathways. Cancer Cell Int. 2021;21:302.","journal-title":"Cancer Cell Int."},{"key":"10055_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12876-018-0870-3","volume":"18","author":"M Huang","year":"2018","unstructured":"Huang M, Huang B, Li G, Zeng S. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2\/RAF\/MEK\/ERK and PI3K\/AKT pathways in cholangiocarcinoma cell. BMC Gastroenterol. 2018;18:169.","journal-title":"BMC Gastroenterol."},{"key":"10055_CR51","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1245\/s10434-025-17320-x","volume":"32","author":"LJ Wang","year":"2025","unstructured":"Wang LJ, Bao Q, Wang HW et al. Predictive factors for chemotherapy response in colorectal liver metastasis: a retrospective study utilizing next-generation sequencing. Ann Surg Oncol. 2025;32:6067\u20136079.","journal-title":"Ann Surg Oncol."},{"key":"10055_CR52","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C Raggi","year":"2022","unstructured":"Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic reprogramming in cholangiocarcinoma. J Hepatol. 2022;77:849\u2013864.","journal-title":"J Hepatol."},{"key":"10055_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ajpath.2015.09.016","volume":"186","author":"C Johnson","year":"2016","unstructured":"Johnson C, Huynh V, Hargrove L et al. Inhibition of mast cell-derived histamine decreases human cholangiocarcinoma growth and differentiation via c-Kit\/Stem cell factor-dependent signaling. Am J Pathol. 2016;186:123\u2013133.","journal-title":"Am J Pathol."},{"key":"10055_CR54","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/gutjnl-2023-331715","volume":"73","author":"A Shi","year":"2024","unstructured":"Shi A, Liu Z, Fan Z et al. Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut. 2024;73:1350\u20131363.","journal-title":"Gut."},{"key":"10055_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/cells11030375","volume":"11","author":"MI Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez MI, Vannan DT, Eksteen B, Flores-Sotelo I, Reyes JL. Mast cells in immune-mediated cholangitis and cholangiocarcinoma. Cells. 2022;11:53.","journal-title":"Cells."},{"key":"10055_CR56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019;19:698\u2013715.","journal-title":"Nat Rev Cancer."},{"key":"10055_CR57","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12885-025-15491-0","volume":"26","author":"X Zheng","year":"2025","unstructured":"Zheng X, Lv C, Guo X. Comprehensive cancer analysis reveals CFH as an immune-related and prognostic marker. BMC Cancer. 2025;26:142.","journal-title":"BMC Cancer."},{"key":"10055_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111253","volume":"40","author":"B Guo","year":"2022","unstructured":"Guo B, Friedland SC, Alexander W et al. Arid1a mutation suppresses TGF-\u03b2 signaling and induces cholangiocarcinoma. Cell Rep. 2022;40:111253.","journal-title":"Cell Rep."},{"key":"10055_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgad011","volume":"44","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Zhao J et al. ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis. 2023;44:197\u2013208.","journal-title":"Carcinogenesis."},{"key":"10055_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41588-019-0541-5","volume":"52","author":"S Nagarajan","year":"2020","unstructured":"Nagarajan S, Rao SV, Sutton J et al. ARID1A influences HDAC1\/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. Nat Genet. 2020;52:187\u2013197.","journal-title":"Nat Genet."},{"key":"10055_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2025.101720","volume":"20","author":"LW Chiou","year":"2026","unstructured":"Chiou LW, Jhuang YL, Hsu CL et al. Pbrm1 loss induces a permissive chromatin state for cholangiocytic differentiation and cholangiocarcinoma formation. Cell Mol Gastroenterol Hepatol. 2026;20:101720.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"10055_CR62","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1038\/s41467-019-13608-1","volume":"10","author":"W Cai","year":"2019","unstructured":"Cai W, Su L, Liao L et al. PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth. Nat Commun. 2019;10:5800.","journal-title":"Nat Commun."},{"key":"10055_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molcel.2015.02.029","volume":"58","author":"BR Sabari","year":"2015","unstructured":"Sabari BR, Tang Z, Huang H et al. Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. Mol Cell. 2015;58:203\u2013215.","journal-title":"Mol Cell."},{"key":"10055_CR64","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/cr.2017.60","volume":"27","author":"W Xu","year":"2017","unstructured":"Xu W, Wan J, Zhan J et al. Global profiling of crotonylation on non-histone proteins. Cell Res. 2017;27:946\u2013949.","journal-title":"Cell Res."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10055-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10055-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10055-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:03:12Z","timestamp":1789628592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10055-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10055"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10055-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publicly available, deidentified data from TCGA and GEO were used in accordance with their respective policies and required no additional ethical approval.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}